[1]
A. Safaei, “Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases”, Gastroenterol Hepatol Bed Bench, vol. 9, no. 3, pp. 158–173, Jun. 2016.